Thymosin oral tablets

Thymosin oral tablets are actually thymosin enteric-coated tablets. Thymosin is a polypeptide that comes from the thymus of calves. This medicine comes as an enteric-coated tablet. It has a good effect in treating primary or secondary T-cell deficiency disorders. It can also be used to treat autoimmune diseases and cellular immune diseases. It can also be used as an auxiliary treatment for tumors. Let’s take a closer look at each one. If you have such a disease, you can choose this medicine.

The main diseases treated include:

1. Various types of severe hepatitis, chronic active hepatitis, chronic persistent hepatitis and liver cirrhosis, etc.;

2. Herpes zoster, genital herpes, condyloma acuminatum, etc.;

3. Bronchitis, bronchial asthma, tuberculosis, prevention of upper respiratory tract infection, etc.;

4. Used in the early stages of various malignant tumors and in combination with chemotherapy and radiotherapy;

5. Lupus erythematosus, rheumatic and rheumatoid diseases, ankylosing spondylitis, Guillain-Barré syndrome, etc.;

6. Aplastic anemia, leukemia, thrombocytopenia, etc.;

7. Viral keratitis, viral conjunctivitis, allergic rhinitis, etc.;

8. Premature aging, menopausal syndrome, etc.;

9. Multiple furuncle and facial skin acne, psoriasis, lichen planus, squamous cell carcinoma and epithelial keratosis, etc.;

10. Congenital immunodeficiency in children, etc.

[Usage and Dosage] Subcutaneous or intramuscular injection: 10-20 mg at a time, once a day or as directed by a doctor. Dissolve in 2 ml of sterile water for injection or 0.9% sodium chloride injection. Intravenous drip: 20-80 mg at a time, once a day or as directed by your doctor. Dissolve in 500ml of 0.9% sodium chloride injection or 5% glucose injection.

[Adverse Reactions] ① Good tolerance, some patients may experience nausea, fever, dizziness, chest tightness, weakness and other adverse reactions, and a few patients may occasionally feel drowsiness. ② Patients with chronic hepatitis B may experience a brief increase in ALT levels when using this product. If there are no signs of liver failure, they can continue to use this product.

③ The State Food and Drug Administration reminds people to pay attention to the serious allergic reactions of thymosin injection:

From 2003 to April 30, 2011, the National Center received 5,459 reports of adverse reactions/events suspected to be related to thymosin injection, of which 1,326 were severe cases, accounting for 24.29%. Serious adverse reactions mainly involved systemic damage (93.74%), including anaphylactic reactions, anaphylactic shock, high fever, etc.; followed by respiratory system damage (5.13%), including dyspnea, laryngeal edema, asthma, chest tightness, and suffocation; damage to the skin and its appendages (0.45%), mainly severe rash. The above serious adverse reactions are all related to allergic reactions.